Diethyl 2,6-dimethyl-4-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-1,4-dihydropyridine-3,5-dicarboxylate

ID: ALA4465625

PubChem CID: 155531263

Max Phase: Preclinical

Molecular Formula: C26H36N2O5

Molecular Weight: 456.58

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1c1ccc(OCCN2CCCCC2)cc1

Standard InChI:  InChI=1S/C26H36N2O5/c1-5-31-25(29)22-18(3)27-19(4)23(26(30)32-6-2)24(22)20-10-12-21(13-11-20)33-17-16-28-14-8-7-9-15-28/h10-13,24,27H,5-9,14-17H2,1-4H3

Standard InChI Key:  ATSZNBUNXOVIFL-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 33 35  0  0  0  0  0  0  0  0999 V2000
    5.5507   -8.0012    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5231   -7.1833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2205   -6.7495    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9420   -7.1357    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9674   -7.9501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2700   -8.3840    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.8016   -6.7971    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7762   -5.9826    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.1077   -7.2287    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.6359   -6.7041    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6082   -5.8861    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.1929   -5.9315    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4735   -5.5488    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4459   -4.7309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1398   -4.2992    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8613   -4.6855    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8867   -5.4999    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1122   -3.4813    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.3907   -3.0950    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3652   -2.2806    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6437   -1.8944    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.9499   -2.3260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2305   -1.9433    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2029   -1.1253    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8968   -0.7013    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6183   -1.0799    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6889   -8.3364    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8568   -8.4329    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3884   -6.8460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3568   -7.0888    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.0505   -6.6569    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7714   -7.0417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6953   -7.2788    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  1  6  1  0
  7  8  2  0
  7  9  1  0
  2  7  1  0
 10 11  2  0
  4 10  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 12 17  2  0
 19 20  1  0
 18 19  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 21 26  1  0
 20 21  1  0
 15 18  1  0
  3 12  1  0
  5 27  1  0
  1 28  1  0
  9 29  1  0
 10 30  1  0
 30 31  1  0
 31 32  1  0
 29 33  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4465625

    ---

Associated Targets(Human)

CACNA1C Tclin Voltage-gated L-type calcium channel (709 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HRH3 Tclin Histamine H3 receptor (10389 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRNE Tclin Acetylcholine receptor protein epsilon chain (95 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 456.58Molecular Weight (Monoisotopic): 456.2624AlogP: 3.91#Rotatable Bonds: 9
Polar Surface Area: 77.10Molecular Species: BASEHBA: 7HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 8.86CX LogP: 3.30CX LogD: 1.83
Aromatic Rings: 1Heavy Atoms: 33QED Weighted: 0.56Np Likeness Score: -0.83

References

1. Malek R, Arribas RL, Palomino-Antolin A, Totoson P, Demougeot C, Kobrlova T, Soukup O, Iriepa I, Moraleda I, Diez-Iriepa D, Godyń J, Panek D, Malawska B, Głuch-Lutwin M, Mordyl B, Siwek A, Chabchoub F, Marco-Contelles J, Kiec-Kononowicz K, Egea J, de Los Ríos C, Ismaili L..  (2019)  New Dual Small Molecules for Alzheimer's Disease Therapy Combining Histamine H3 Receptor (H3R) Antagonism and Calcium Channels Blockade with Additional Cholinesterase Inhibition.,  62  (24): [PMID:31724859] [10.1021/acs.jmedchem.9b00937]

Source